Adamis Pharmaceuticals Corp - FORM 10-Q - EX-32.1 - CERFICATION OF CHIEF EXECUTIVE OFFICER - February 19, 2013

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - Adamis Pharmaceuticals CorpFinancial_Report.xls
10-Q - QUARTERLY REPORT - Adamis Pharmaceuticals Corpadmp-10q_123112.htm
EX-10.1 - ZERO COUPON SECURED PROMISSORY NOTE DATED OCTOBER 25, 2012 - Adamis Pharmaceuticals Corpex10_1.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - Adamis Pharmaceuticals Corpex31_1.htm
EX-10.2 - CONVERTIBLE PROMISSORY NOTE DATED DECEMBER 31, 2012 - Adamis Pharmaceuticals Corpex10_2.htm
EX-32.2 - CERTIFICATION OF VICE PRESIDENT, FINANCE AND CHIEF FINANCIAL OFFICER - Adamis Pharmaceuticals Corpex32_2.htm
EX-31.2 - CERTIFICATION OF VICE PRESIDENT, FINANCE AND CHIEF FINANCIAL OFFICER - Adamis Pharmaceuticals Corpex31_2.htm
 
EXHIBIT 32.1
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT
 
The undersigned, Dennis J. Carlo, the Chief Executive Officer of Adamis Pharmaceuticals Corporation (the “Company”), pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, hereby certifies that, to the best of my knowledge:
 
 
(1)
the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2012 (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
     
 
(2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 19, 2013
By:
/s/ Dennis J. Carlo
   
Dennis J. Carlo
   
Chief Executive Officer

This certification is being furnished to the SEC with this Report on Form 10-Q pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.
 
 

Stock widget

Investing forum

Adamis Pharmaceuticals Corp Reports